The health insurance marketplace’s application/verification process is vulnerable to fraud, found a report from the US Government Accountability Office.
The health insurance marketplace’s application/verification process is vulnerable to fraud, and the marketplace not resolve about one-third of applicant inconsistencies for coverage year 2014, involving $1.7 billion in associated subsidies, according to a report from the US Government Accountability Office (GAO).
Following a Congressional request that the GAO examine the enrollment process and verification controls of the Patient Protection and Affordable Care Act (ACA)’s federal Marketplace, the GAO issued a report with 8 recommendations, including that CMS consider analyzing outcomes of the verification system, take steps to resolve inconsistencies, and conduct a risk assessment of the potential for fraud in Marketplace applications. CMS operates the federal Marketplace in approximately two-thirds of the states.
The ACA provides subsidies to people purchasing private health insurance plans who meet certain income and other requirements that are estimated (with related spending) to cost $37 billion for fiscal year 2015, rising to $105 billion for fiscal year 2025, and totaling $880 billion for fiscal years 2016 to 2025. The GAO report explained that because subsidy costs are contingent on being eligible for coverage, enrollment controls that help ensure only qualified applicants are approved for subsidies are key to determining federal expenditures under the ACA. The federal “data hub” is central to enrollment controls and provides a way to check applicant-provided information against a variety of data sources.
The report was based on federal Marketplace data from January 2014 to February 2016 and examined the extent to which applicant-submitted information is verified through an electronic system, and the extent to which the federal Marketplace resolved “inconsistencies” in which applicant information does not match information from federal data sources. It also described, by means of undercover testing and related work, potential vulnerabilities to fraud in the federal Marketplace’s application, enrollment, and eligibility verification processes.
“A greater understanding of the effectiveness of the data hub process could inform assessments about effectiveness of enrollment and eligibility controls, while still incorporating procedures that seek to safeguard applicant information,” the report noted, and recommended a set of actions CMS should take to better oversee the efficacy of the ACA’s enrollment control process; to better monitor costs, risk, and program performance; to assist with tax compliance; to strengthen the eligibility determination process; to provide applicants with improved customer service and up-to-date information about submission of eligibility documentation; and to better document agency activities.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More